Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

David Badesch

Concepts (509)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension, Pulmonary
115
2025
1957
6.550
 Why?
Antihypertensive Agents
33
2025
521
2.790
 Why?
Epoprostenol
23
2015
132
1.780
 Why?
Recombinant Fusion Proteins
9
2025
666
1.400
 Why?
Vasodilator Agents
12
2015
330
1.090
 Why?
Vascular Resistance
11
2025
370
1.010
 Why?
Registries
22
2025
2410
0.980
 Why?
Familial Primary Pulmonary Hypertension
17
2024
196
0.950
 Why?
Pulmonary Wedge Pressure
9
2024
67
0.910
 Why?
Piperazines
8
2014
375
0.860
 Why?
Sulfones
7
2012
127
0.850
 Why?
Exercise Tolerance
21
2025
283
0.850
 Why?
Hemodynamics
30
2024
1118
0.830
 Why?
Scleroderma, Systemic
7
2021
123
0.720
 Why?
Connective Tissue Diseases
5
2018
85
0.700
 Why?
Practice Guidelines as Topic
7
2020
1582
0.680
 Why?
Exercise Test
12
2025
630
0.670
 Why?
Sulfonamides
13
2018
583
0.670
 Why?
Double-Blind Method
26
2025
2064
0.660
 Why?
Respiratory System Agents
2
2023
22
0.610
 Why?
Natriuretic Peptide, Brain
10
2025
109
0.610
 Why?
Phenylpropionates
5
2011
27
0.610
 Why?
Pulmonary Artery
14
2023
1129
0.580
 Why?
Pyridazines
5
2011
57
0.550
 Why?
Adult
79
2025
40881
0.540
 Why?
Cardiac Catheterization
13
2024
559
0.530
 Why?
Endothelin Receptor Antagonists
10
2015
61
0.530
 Why?
Humans
146
2025
145783
0.510
 Why?
Middle Aged
81
2025
36309
0.500
 Why?
Activins
2
2025
29
0.450
 Why?
Treatment Outcome
34
2025
11794
0.440
 Why?
Pyrimidines
4
2024
530
0.440
 Why?
Lung Transplantation
10
2025
332
0.410
 Why?
Disease Management
6
2016
653
0.410
 Why?
Male
93
2025
73011
0.400
 Why?
Female
90
2025
79045
0.390
 Why?
Aged
44
2025
26217
0.370
 Why?
Risk Assessment
14
2024
3752
0.360
 Why?
Consensus
1
2014
479
0.360
 Why?
Thrombosis
1
2016
400
0.360
 Why?
Anemia, Sickle Cell
5
2014
318
0.350
 Why?
Anticoagulants
3
2016
748
0.340
 Why?
Pyrazoles
3
2024
517
0.330
 Why?
Prognosis
16
2021
4330
0.320
 Why?
Thinness
1
2011
100
0.320
 Why?
Prostaglandins
3
2007
94
0.310
 Why?
Survival Rate
15
2022
2094
0.310
 Why?
Blood Pressure
8
2014
1782
0.290
 Why?
Oxygen Consumption
1
2012
719
0.290
 Why?
Hypertension, Portal
4
2011
66
0.290
 Why?
Activities of Daily Living
3
2016
444
0.280
 Why?
Sildenafil Citrate
8
2014
60
0.280
 Why?
Follow-Up Studies
18
2025
5428
0.280
 Why?
Coagulants
1
2008
20
0.270
 Why?
Factor VIIa
1
2008
43
0.270
 Why?
Lung Neoplasms
1
2021
2668
0.260
 Why?
Hospitalization
9
2025
2461
0.260
 Why?
Purines
8
2014
187
0.260
 Why?
Depressive Disorder
1
2010
374
0.250
 Why?
Surveys and Questionnaires
2
2018
6085
0.250
 Why?
Drug Therapy, Combination
8
2025
1043
0.250
 Why?
Quality of Life
12
2025
3211
0.250
 Why?
Mixed Connective Tissue Disease
2
2010
10
0.250
 Why?
Evidence-Based Medicine
4
2019
740
0.250
 Why?
Health Status
2
2016
835
0.230
 Why?
Bone Morphogenetic Protein Receptors, Type II
2
2025
51
0.230
 Why?
Pulmonary Medicine
3
2019
78
0.230
 Why?
Prospective Studies
16
2021
8078
0.220
 Why?
Phosphodiesterase 5 Inhibitors
3
2014
40
0.220
 Why?
Pulmonary Disease, Chronic Obstructive
1
2012
920
0.210
 Why?
Hemorrhage
2
2008
822
0.210
 Why?
Dose-Response Relationship, Drug
11
2021
2028
0.210
 Why?
Castleman Disease
1
2003
16
0.200
 Why?
Walk Test
4
2025
82
0.190
 Why?
Herpesvirus 8, Human
1
2003
67
0.190
 Why?
DEAE-Dextran
1
2023
1
0.190
 Why?
Referral and Consultation
2
2025
869
0.190
 Why?
United States
21
2025
16126
0.190
 Why?
Muscle, Smooth, Vascular
6
1994
450
0.180
 Why?
Phosphodiesterase Inhibitors
4
2009
73
0.180
 Why?
Peptide Fragments
5
2025
697
0.180
 Why?
Herpesviridae Infections
1
2003
148
0.180
 Why?
Disease Progression
6
2025
2865
0.180
 Why?
Adolescent
22
2021
22577
0.180
 Why?
Body Mass Index
1
2011
2447
0.180
 Why?
Ventricular Function, Right
5
2009
297
0.180
 Why?
Biomarkers
6
2021
4302
0.170
 Why?
Insulin-Like Growth Factor I
4
1994
317
0.170
 Why?
Lung
7
2019
4116
0.160
 Why?
Fluid Shifts
1
2020
2
0.160
 Why?
Medication Adherence
1
2025
540
0.160
 Why?
Adenocarcinoma, Mucinous
1
2021
76
0.160
 Why?
Severity of Illness Index
10
2024
2933
0.160
 Why?
Rituximab
1
2021
210
0.160
 Why?
Exercise Therapy
1
2025
475
0.160
 Why?
Kaplan-Meier Estimate
5
2025
971
0.160
 Why?
Heart
2
2023
626
0.160
 Why?
Methamphetamine
1
2021
74
0.160
 Why?
Infusions, Intravenous
7
2009
428
0.160
 Why?
Vasculitis
2
1998
69
0.150
 Why?
Somatomedins
2
1990
28
0.150
 Why?
Echocardiography
4
2020
648
0.150
 Why?
Walking
8
2014
545
0.150
 Why?
Sodium Chloride
1
2020
138
0.150
 Why?
Thorax
1
2019
51
0.150
 Why?
Diagnostic Techniques, Respiratory System
1
2019
5
0.150
 Why?
Endothelin A Receptor Antagonists
2
2011
24
0.150
 Why?
HLA-DP alpha-Chains
1
2018
4
0.140
 Why?
Isoxazoles
3
2008
56
0.140
 Why?
Immunologic Factors
1
2021
260
0.140
 Why?
SOXF Transcription Factors
1
2018
16
0.140
 Why?
Thiophenes
3
2008
117
0.140
 Why?
Transforming Growth Factor beta
1
2021
474
0.140
 Why?
HLA-DP beta-Chains
1
2018
88
0.140
 Why?
Administration, Oral
9
2015
867
0.130
 Why?
Time Factors
14
2018
7134
0.130
 Why?
Young Adult
10
2021
14254
0.130
 Why?
Liver Diseases
3
2011
305
0.130
 Why?
Algorithms
5
2019
1851
0.130
 Why?
Blood Coagulation
2
2016
274
0.130
 Why?
Obesity
1
2011
3118
0.130
 Why?
Psychometrics
2
2018
732
0.120
 Why?
Comorbidity
5
2019
1662
0.120
 Why?
Proportional Hazards Models
6
2022
1330
0.120
 Why?
Diagnostic Imaging
1
2019
337
0.120
 Why?
Oxygen Inhalation Therapy
1
2018
181
0.120
 Why?
B-Lymphocytes
1
2021
872
0.110
 Why?
Randomized Controlled Trials as Topic
5
2024
1752
0.110
 Why?
Pyridines
2
2015
609
0.110
 Why?
Iloprost
2
2006
45
0.110
 Why?
Drug Monitoring
1
2019
401
0.110
 Why?
Calcium Channel Blockers
2
2024
166
0.110
 Why?
Pulmonary Edema
1
1995
105
0.110
 Why?
Tetrazoles
1
2015
50
0.110
 Why?
Cohort Studies
7
2020
6033
0.110
 Why?
Graft Rejection
1
1998
521
0.100
 Why?
Survival Analysis
8
2018
1378
0.100
 Why?
Hemolysis
2
2014
242
0.100
 Why?
Models, Theoretical
2
2015
560
0.100
 Why?
Case-Control Studies
5
2018
3634
0.100
 Why?
Antibodies, Antinuclear
1
1993
62
0.100
 Why?
Pilot Projects
4
2010
1898
0.100
 Why?
Acute Disease
3
2008
1036
0.100
 Why?
Protein Kinase C
2
1994
251
0.100
 Why?
Hypothyroidism
1
1993
68
0.090
 Why?
Societies, Medical
2
2015
900
0.090
 Why?
Pancreatic Neoplasms
1
2021
928
0.090
 Why?
Echocardiography, Doppler
2
2014
115
0.090
 Why?
Colorado
3
2022
4556
0.090
 Why?
Respiratory Function Tests
5
2018
544
0.090
 Why?
Delphi Technique
1
2014
333
0.090
 Why?
Exercise
4
2024
2205
0.090
 Why?
Endpoint Determination
2
2010
85
0.090
 Why?
Incidence
5
2015
2934
0.090
 Why?
Injections, Subcutaneous
2
2023
170
0.090
 Why?
Pulmonary Circulation
3
2018
430
0.090
 Why?
Patient Reported Outcome Measures
1
2016
498
0.090
 Why?
Survival
1
2011
38
0.080
 Why?
Diagnosis, Differential
3
2020
1512
0.080
 Why?
Peptidyl-Dipeptidase A
3
2003
56
0.080
 Why?
Risk Factors
9
2018
10919
0.080
 Why?
Pain
2
2011
791
0.080
 Why?
United Kingdom
3
2021
358
0.080
 Why?
Extracorporeal Membrane Oxygenation
1
1995
390
0.080
 Why?
Prevalence
4
2010
2875
0.080
 Why?
Long-Term Care
1
2011
118
0.080
 Why?
Reference Values
2
2009
798
0.080
 Why?
Michigan
1
2010
134
0.080
 Why?
Respiration, Artificial
1
1995
714
0.080
 Why?
Animals, Newborn
5
1994
896
0.080
 Why?
Endothelin-1
2
2002
181
0.070
 Why?
Retrospective Studies
8
2025
17330
0.070
 Why?
Pulmonary Alveoli
2
2005
387
0.070
 Why?
Guideline Adherence
2
2018
587
0.070
 Why?
Aldosterone
1
2009
42
0.070
 Why?
Dinoprostone
1
1989
180
0.070
 Why?
Elastin
1
1989
78
0.070
 Why?
Pulmonary Eosinophilia
1
1989
27
0.070
 Why?
Vasopressins
1
2009
61
0.070
 Why?
Transaminases
1
2008
22
0.070
 Why?
Serotonin Plasma Membrane Transport Proteins
1
2009
62
0.070
 Why?
Vasoconstrictor Agents
1
2009
150
0.070
 Why?
Renal Insufficiency
1
2010
172
0.070
 Why?
Ventricular Dysfunction, Left
1
2011
394
0.070
 Why?
Alveolitis, Extrinsic Allergic
1
1989
93
0.070
 Why?
Maximum Tolerated Dose
2
2025
211
0.070
 Why?
Aged, 80 and over
8
2021
8347
0.070
 Why?
Hospitals, University
1
2008
176
0.070
 Why?
Multivariate Analysis
4
2015
1547
0.070
 Why?
Lung Diseases
2
2010
782
0.070
 Why?
Heart Failure
2
2020
2326
0.060
 Why?
Genetic Predisposition to Disease
3
2018
2399
0.060
 Why?
Platelet Aggregation Inhibitors
3
2004
499
0.060
 Why?
Ventricular Dysfunction, Right
3
2009
248
0.060
 Why?
Lupus Erythematosus, Systemic
3
2010
238
0.060
 Why?
Airway Obstruction
1
2009
153
0.060
 Why?
Drug Utilization
1
2008
168
0.060
 Why?
Endothelins
1
2007
61
0.060
 Why?
Drug Costs
1
2008
117
0.060
 Why?
Hypophosphatemia
1
2006
17
0.060
 Why?
Hypokalemia
1
2006
24
0.060
 Why?
Appetite Depressants
1
2006
19
0.060
 Why?
Clinical Trials as Topic
2
2009
1062
0.060
 Why?
Autoimmune Diseases
2
2005
469
0.060
 Why?
Phosphorus
1
2006
90
0.060
 Why?
Educational Measurement
1
1989
326
0.060
 Why?
Potassium
1
2006
152
0.060
 Why?
Ventricular Function
1
2006
53
0.060
 Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2005
17
0.060
 Why?
Cattle
5
1994
946
0.060
 Why?
Telangiectasis
1
2025
7
0.060
 Why?
Epistaxis
1
2025
17
0.060
 Why?
Medical Informatics
1
2006
100
0.060
 Why?
CREST Syndrome
2
2002
6
0.060
 Why?
Pleural Diseases
1
2005
23
0.060
 Why?
Analysis of Variance
3
2009
1300
0.060
 Why?
Probability
3
2015
308
0.060
 Why?
Forecasting
3
2021
390
0.050
 Why?
Immunohistochemistry
3
2005
1723
0.050
 Why?
Child
6
2011
22740
0.050
 Why?
Recombinant Proteins
1
2008
1368
0.050
 Why?
Clinical Trials, Phase III as Topic
1
2024
116
0.050
 Why?
Predictive Value of Tests
3
2016
2123
0.050
 Why?
Arthritis, Rheumatoid
3
2010
1180
0.050
 Why?
Carbon Monoxide
2
2018
82
0.050
 Why?
Heterozygote
1
2025
314
0.050
 Why?
Physicians, Family
1
2005
177
0.050
 Why?
Age Distribution
3
2010
404
0.050
 Why?
Sex Distribution
3
2010
388
0.050
 Why?
Physician's Role
1
2005
225
0.050
 Why?
Terminology as Topic
1
2005
259
0.050
 Why?
Neoplasm Metastasis
1
2005
688
0.050
 Why?
Polymyositis
1
2002
13
0.050
 Why?
Statistics, Nonparametric
2
2003
428
0.050
 Why?
Scleroderma, Localized
1
2002
11
0.050
 Why?
Dermatomyositis
1
2002
24
0.050
 Why?
Serotonin Antagonists
1
2002
32
0.050
 Why?
Heart Defects, Congenital
2
2009
910
0.050
 Why?
Thromboxane-A Synthase
1
2002
3
0.050
 Why?
Liver Function Tests
3
2011
105
0.050
 Why?
Enzyme Inhibitors
2
2004
821
0.040
 Why?
Polymerase Chain Reaction
2
2003
1043
0.040
 Why?
Hypoxia
3
2018
1199
0.040
 Why?
Drug Administration Schedule
4
2008
782
0.040
 Why?
Cardiac Surgical Procedures
1
2008
611
0.040
 Why?
Mutation
2
2025
4090
0.040
 Why?
Signal Transduction
4
2025
5224
0.040
 Why?
Animals
11
2013
38102
0.040
 Why?
Biomarkers, Pharmacological
1
2021
26
0.040
 Why?
Cholangiopancreatography, Magnetic Resonance
1
2021
24
0.040
 Why?
Tricuspid Valve Insufficiency
2
2011
24
0.040
 Why?
Cardiovascular Agents
1
2023
166
0.040
 Why?
Clinical Competence
1
1989
1247
0.040
 Why?
Least-Squares Analysis
1
2021
73
0.040
 Why?
Polymorphism, Single Nucleotide
3
2018
2181
0.040
 Why?
Injections, Intravenous
2
2013
197
0.040
 Why?
Adjuvants, Immunologic
1
2002
244
0.040
 Why?
Multicenter Studies as Topic
2
2006
413
0.040
 Why?
Tropoelastin
2
1991
11
0.040
 Why?
Reproductive History
1
2020
12
0.040
 Why?
Cells, Cultured
5
1994
4151
0.040
 Why?
Risk
2
2015
923
0.040
 Why?
Self Report
1
2025
876
0.040
 Why?
Lymph Nodes
1
2003
509
0.040
 Why?
Europe
2
2012
421
0.040
 Why?
Infusion Pumps
1
2000
33
0.040
 Why?
Jaw
1
2000
27
0.040
 Why?
Cardiac Output
1
2020
179
0.040
 Why?
Radiography
2
1995
853
0.040
 Why?
Genotype
4
2009
1857
0.040
 Why?
Delivery of Health Care
1
2006
948
0.040
 Why?
Transplantation, Homologous
2
1998
419
0.040
 Why?
Placebos
2
2011
193
0.040
 Why?
Autoimmunity
1
2005
933
0.040
 Why?
Reproducibility of Results
2
2019
3418
0.040
 Why?
Symptom Assessment
1
2020
136
0.040
 Why?
Spinal Diseases
1
1999
50
0.040
 Why?
Intramolecular Oxidoreductases
1
1999
65
0.040
 Why?
Gonadal Steroid Hormones
1
2020
143
0.040
 Why?
Thrombocytopenia
1
2021
204
0.040
 Why?
Lung Diseases, Interstitial
1
2005
664
0.040
 Why?
Internship and Residency
1
1989
1269
0.040
 Why?
Uric Acid
1
2000
167
0.040
 Why?
Genotyping Techniques
1
2018
71
0.030
 Why?
Cytochrome P-450 Enzyme System
1
1999
162
0.030
 Why?
Methicillin Resistance
1
1998
17
0.030
 Why?
Plasmapheresis
1
1998
24
0.030
 Why?
Immunosuppressive Agents
3
1998
838
0.030
 Why?
Cell Division
4
1994
757
0.030
 Why?
Pulmonary Diffusing Capacity
1
2018
78
0.030
 Why?
Hemoptysis
1
1998
35
0.030
 Why?
Bronchiolitis Obliterans
1
1998
61
0.030
 Why?
Models, Statistical
1
2022
672
0.030
 Why?
Gastrointestinal Diseases
1
2000
222
0.030
 Why?
Cervical Vertebrae
1
1999
169
0.030
 Why?
alpha 1-Antitrypsin Deficiency
1
1998
61
0.030
 Why?
Disease-Free Survival
2
2010
770
0.030
 Why?
Fatal Outcome
1
1998
305
0.030
 Why?
Biomedical Technology
1
2017
50
0.030
 Why?
Capillaries
1
1998
125
0.030
 Why?
Child, Preschool
2
2011
11868
0.030
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1997
43
0.030
 Why?
Health Status Indicators
2
2009
167
0.030
 Why?
Myosin Heavy Chains
1
1997
183
0.030
 Why?
Faculty, Medical
2
1990
305
0.030
 Why?
Colonic Diseases
1
1996
37
0.030
 Why?
Mycoplasma
1
1996
5
0.030
 Why?
Intestinal Perforation
1
1996
46
0.030
 Why?
Mycoplasma Infections
1
1996
17
0.030
 Why?
Desensitization, Immunologic
1
1997
89
0.030
 Why?
Translating
1
2016
50
0.030
 Why?
Mass Screening
2
2018
1361
0.030
 Why?
Cardiomyopathy, Dilated
1
1999
356
0.030
 Why?
Blood Coagulation Factors
1
1996
71
0.030
 Why?
Drug Hypersensitivity
1
1997
90
0.030
 Why?
Myocardium
2
1998
935
0.030
 Why?
Comparative Effectiveness Research
1
2016
169
0.030
 Why?
Dyspnea
2
2008
250
0.030
 Why?
Endothelium, Vascular
2
1994
956
0.030
 Why?
Pulmonary Emphysema
1
1998
277
0.030
 Why?
Fibrinolysis
1
1996
164
0.030
 Why?
Lactobacillus
1
1994
28
0.030
 Why?
Calibration
1
2015
152
0.030
 Why?
Recurrence
1
1998
1139
0.030
 Why?
Tetradecanoylphorbol Acetate
2
1994
149
0.030
 Why?
Immunization, Passive
1
1994
90
0.030
 Why?
Drug Approval
1
2015
93
0.030
 Why?
Longitudinal Studies
2
2014
2968
0.030
 Why?
Antisickling Agents
1
2014
7
0.030
 Why?
Ferritins
1
2014
70
0.030
 Why?
South Africa
1
2015
266
0.030
 Why?
Hydroxyurea
1
2014
34
0.030
 Why?
Immunoglobulins
1
1994
163
0.030
 Why?
United States Food and Drug Administration
1
2015
208
0.030
 Why?
Social Behavior
1
2016
284
0.020
 Why?
Gram-Positive Bacterial Infections
1
1994
72
0.020
 Why?
Thyroiditis
1
1993
4
0.020
 Why?
Raynaud Disease
1
1993
3
0.020
 Why?
Staphylococcal Infections
1
1998
393
0.020
 Why?
Cytomegalovirus
1
1994
168
0.020
 Why?
Genetic Variation
1
2018
977
0.020
 Why?
Research
2
2009
431
0.020
 Why?
Cross-Sectional Studies
3
2016
5925
0.020
 Why?
Pneumonia, Bacterial
1
1994
113
0.020
 Why?
Administration, Intravenous
1
2014
172
0.020
 Why?
Focus Groups
1
2016
572
0.020
 Why?
Immunoenzyme Techniques
2
1994
200
0.020
 Why?
Enzyme Activation
2
1994
762
0.020
 Why?
Emergency Service, Hospital
1
2025
2383
0.020
 Why?
Erythrocyte Indices
1
2012
33
0.020
 Why?
Blood Flow Velocity
1
2014
421
0.020
 Why?
Cytomegalovirus Infections
1
1994
206
0.020
 Why?
Down Syndrome
1
1999
525
0.020
 Why?
Pulmonary Embolism
1
2015
241
0.020
 Why?
Creatinine
1
2014
515
0.020
 Why?
Embolism, Air
1
1992
14
0.020
 Why?
Genome-Wide Association Study
1
2018
1430
0.020
 Why?
Erythrocyte Transfusion
1
2014
225
0.020
 Why?
Cell-Derived Microparticles
1
2012
73
0.020
 Why?
Chronic Disease
2
2015
1812
0.020
 Why?
Preoperative Care
2
2009
380
0.020
 Why?
Cardiomegaly
2
2006
174
0.020
 Why?
Homozygote
1
2011
199
0.020
 Why?
Biomedical Research
1
2017
719
0.020
 Why?
Emotions
1
2016
577
0.020
 Why?
Thromboxane B2
1
1989
23
0.020
 Why?
Calcimycin
1
1989
36
0.020
 Why?
Mortality
1
2012
381
0.020
 Why?
Phenotype
3
2010
3170
0.020
 Why?
Nitric Oxide
1
1994
892
0.020
 Why?
Drug Synergism
1
1990
354
0.020
 Why?
Mental Health
1
2016
796
0.020
 Why?
Cost-Benefit Analysis
1
2012
644
0.020
 Why?
Decision Support Techniques
1
2014
480
0.020
 Why?
Angiopoietin-1
1
2009
12
0.020
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2009
23
0.020
 Why?
Health Policy
1
2012
400
0.020
 Why?
Receptors, Retinoic Acid
1
2009
44
0.020
 Why?
Aromatase
1
2009
37
0.020
 Why?
Spironolactone
1
2009
40
0.020
 Why?
Nucleic Acid Hybridization
1
1989
187
0.020
 Why?
Health Care Costs
1
2012
425
0.020
 Why?
Fellowships and Scholarships
2
1990
354
0.020
 Why?
Dyspepsia
1
2008
11
0.020
 Why?
Hepatitis, Autoimmune
1
2008
14
0.020
 Why?
Pulmonary Veins
1
1989
108
0.020
 Why?
In Vitro Techniques
1
1990
1049
0.020
 Why?
California
1
2010
473
0.020
 Why?
Mineralocorticoid Receptor Antagonists
1
2009
69
0.020
 Why?
Qualitative Research
1
2016
1683
0.020
 Why?
Vital Capacity
1
2009
292
0.020
 Why?
Confidence Intervals
1
2009
330
0.020
 Why?
Vibrio Infections
1
1987
2
0.020
 Why?
Echocardiography, Transesophageal
1
2009
132
0.020
 Why?
Down-Regulation
1
1990
618
0.020
 Why?
Cystic Fibrosis
1
1998
1163
0.020
 Why?
Forced Expiratory Volume
1
2009
450
0.020
 Why?
Cognition
1
2016
1271
0.020
 Why?
Calcium-Binding Proteins
1
2009
221
0.020
 Why?
Estrogen Receptor alpha
1
2009
151
0.020
 Why?
Headache
1
2008
151
0.020
 Why?
American Heart Association
1
2009
358
0.020
 Why?
Endocarditis, Bacterial
1
1987
46
0.020
 Why?
Aminorex
1
2006
2
0.020
 Why?
RNA, Messenger
2
1997
2805
0.010
 Why?
Heart Rate
1
2010
856
0.010
 Why?
Protein Biosynthesis
1
1989
452
0.010
 Why?
Odds Ratio
1
2009
1083
0.010
 Why?
Alleles
1
2009
896
0.010
 Why?
Hypoventilation
1
1985
17
0.010
 Why?
Hepatitis C
1
2008
256
0.010
 Why?
Biopsy, Needle
1
2005
185
0.010
 Why?
Statistics as Topic
1
2006
283
0.010
 Why?
Estradiol
1
2009
515
0.010
 Why?
Gene Expression Regulation
2
1997
2601
0.010
 Why?
Magnesium
1
1985
157
0.010
 Why?
Magnetic Resonance Imaging
3
2006
3916
0.010
 Why?
Pancreatic Elastase
1
2004
53
0.010
 Why?
Drug Prescriptions
1
2006
288
0.010
 Why?
Hypotension
1
1985
127
0.010
 Why?
Fibroblasts
1
1989
1028
0.010
 Why?
Sensitivity and Specificity
1
2009
2000
0.010
 Why?
DNA
1
1990
1437
0.010
 Why?
Aging
1
1994
1973
0.010
 Why?
Logistic Models
1
2009
2139
0.010
 Why?
Potassium Channels
1
2004
148
0.010
 Why?
Tablets
1
2003
41
0.010
 Why?
Critical Care
1
1989
702
0.010
 Why?
Research Design
1
2009
1139
0.010
 Why?
Arginine
1
2004
264
0.010
 Why?
Angiotensin II
1
2003
102
0.010
 Why?
Sex Factors
1
2008
2110
0.010
 Why?
Rats
2
2004
5585
0.010
 Why?
Liver Transplantation
1
2009
827
0.010
 Why?
Attitude of Health Personnel
1
2010
1197
0.010
 Why?
Heart Ventricles
1
2006
756
0.010
 Why?
Sepsis
1
1987
664
0.010
 Why?
Practice Patterns, Physicians'
1
2010
1372
0.010
 Why?
Colorimetry
1
2000
12
0.010
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2004
444
0.010
 Why?
Spinal Osteophytosis
1
1999
3
0.010
 Why?
Spinal Cord Compression
1
1999
24
0.010
 Why?
Ovarian Neoplasms
1
2005
596
0.010
 Why?
Spinal Stenosis
1
1999
31
0.010
 Why?
Veins
1
1999
69
0.010
 Why?
Heart Atria
1
2000
141
0.010
 Why?
In Situ Hybridization
1
1999
318
0.010
 Why?
Calcium-Transporting ATPases
1
1997
33
0.010
 Why?
Atrial Natriuretic Factor
1
1997
55
0.010
 Why?
Arteries
1
1999
261
0.010
 Why?
Heart-Lung Transplantation
1
1997
13
0.010
 Why?
Receptors, Adrenergic, beta
1
1997
58
0.010
 Why?
Tissue Distribution
1
1997
335
0.010
 Why?
Liver Cirrhosis
1
1999
288
0.010
 Why?
Models, Biological
1
2004
1764
0.010
 Why?
Spinal Cord
1
1999
382
0.010
 Why?
Diverticulitis, Colonic
1
1996
10
0.010
 Why?
Systole
1
1997
181
0.010
 Why?
Blotting, Western
1
1999
1184
0.010
 Why?
von Willebrand Factor
1
1996
85
0.010
 Why?
Respiration
1
1996
207
0.010
 Why?
Proteins
2
1992
1023
0.010
 Why?
Physical Fitness
1
1997
207
0.010
 Why?
Ventricular Function, Left
1
1999
544
0.010
 Why?
Cilazapril
1
1995
1
0.010
 Why?
Electrophoresis, Agar Gel
1
1995
25
0.010
 Why?
Thymidine
1
1994
60
0.010
 Why?
Ganciclovir
1
1994
53
0.010
 Why?
Subcellular Fractions
1
1994
73
0.010
 Why?
Lung Diseases, Obstructive
1
1994
43
0.010
 Why?
Opportunistic Infections
1
1994
47
0.010
 Why?
Image Processing, Computer-Assisted
1
1999
783
0.010
 Why?
Acyclovir
1
1994
98
0.010
 Why?
Blood
1
1994
107
0.010
 Why?
Tissue Donors
1
1997
420
0.010
 Why?
Vimentin
1
1994
54
0.010
 Why?
Immunoglobulins, Intravenous
1
1994
133
0.010
 Why?
Viremia
1
1994
160
0.010
 Why?
Gene Expression
1
1998
1478
0.010
 Why?
Factor VIII
1
1994
106
0.010
 Why?
Liver
1
2002
1899
0.010
 Why?
Administration, Inhalation
1
1994
571
0.010
 Why?
Immunocompromised Host
1
1994
202
0.010
 Why?
Sputum
1
1994
302
0.010
 Why?
Neovascularization, Pathologic
1
1994
287
0.010
 Why?
Lymph
1
1992
31
0.010
 Why?
Blotting, Northern
1
1991
203
0.010
 Why?
Flow Cytometry
1
1994
1165
0.000
 Why?
Extracellular Matrix Proteins
1
1991
156
0.000
 Why?
Antibodies, Viral
1
1994
674
0.000
 Why?
Financing, Government
1
1990
53
0.000
 Why?
Research Support as Topic
1
1990
81
0.000
 Why?
Career Mobility
1
1990
68
0.000
 Why?
National Institutes of Health (U.S.)
1
1990
148
0.000
 Why?
Pneumonia, Viral
1
1994
391
0.000
 Why?
Rats, Sprague-Dawley
1
1995
2525
0.000
 Why?
Sheep
1
1992
876
0.000
 Why?
Tomography, X-Ray Computed
1
1999
2770
0.000
 Why?
Vibrio
1
1987
4
0.000
 Why?
Hepatitis, Alcoholic
1
1987
16
0.000
 Why?
Citrates
1
1985
41
0.000
 Why?
Protein Binding
1
1992
2240
0.000
 Why?
RNA
1
1991
912
0.000
 Why?
Kidney Function Tests
1
1985
156
0.000
 Why?
Postoperative Complications
1
1997
2977
0.000
 Why?
Disease Models, Animal
1
1995
4568
0.000
 Why?
HIV Infections
1
1999
3195
0.000
 Why?
Anti-Bacterial Agents
1
1994
1925
0.000
 Why?
Infant
1
1994
10091
0.000
 Why?
Badesch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (509) concept(s)
_
Co-Authors Expand Description
See all (36) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)